🇺🇸 FDA
Pipeline program

PERSERIS

INDV-7000-401

Approved small_molecule completed

Quick answer

PERSERIS for Schizophrenia is a Approved program (small_molecule) at Indivior Europe Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Indivior Europe Limited
Indication
Schizophrenia
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials